Cite
ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviates the symptoms of type 2 diabetes.
MLA
Cho, Haaglim, et al. “ENOblock, a Unique Small Molecule Inhibitor of the Non-Glycolytic Functions of Enolase, Alleviates the Symptoms of Type 2 Diabetes.” Scientific Reports, Mar. 2017, p. 44186. EBSCOhost, https://doi.org/10.1038/srep44186.
APA
Cho, H., Um, J., Lee, J.-H., Kim, W.-H., Kang, W. S., Kim, S. H., Ha, H.-H., Kim, Y.-C., Ahn, Y.-K., Jung, D.-W., & Williams, D. R. (2017). ENOblock, a unique small molecule inhibitor of the non-glycolytic functions of enolase, alleviates the symptoms of type 2 diabetes. Scientific Reports, 44186. https://doi.org/10.1038/srep44186
Chicago
Cho, Haaglim, JungIn Um, Ji-Hyung Lee, Woong-Hee Kim, Wan Seok Kang, So Hun Kim, Hyung-Ho Ha, et al. 2017. “ENOblock, a Unique Small Molecule Inhibitor of the Non-Glycolytic Functions of Enolase, Alleviates the Symptoms of Type 2 Diabetes.” Scientific Reports, March, 44186. doi:10.1038/srep44186.